Glucagon-like peptide-1 receptor agonists improve hepatic histology and metabolic parameters in type 2 diabetes with MASLD: a meta-analysis of randomized controlled trials
Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent condition with limited pharmacological options. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as potential therapies for MASLD, but their efficacy and safety have not been compreh...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BMC
2026-05-01
|
| Σειρά: | Diabetology & Metabolic Syndrome |
| Θέματα: | |
| Διαθέσιμο Online: | https://doi.org/10.1186/s13098-026-02179-z |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|